InspireMD Q4 EPS $(0.14) Beats $(0.19) Estimate, Sales $3.149M Beat $2.626M Estimate

InspireMD (NASDAQ: NSPR) reported a Q4 loss of $(0.14) per share, surpassing the analyst estimate of $(0.19) by 27.46%. The company's quarterly sales reached $3.149 million, exceeding expectations of $2.626 million by 19.93%, and marking a 61.57% increase from $1.949 million in the same period last year.